Actively Recruiting
Global Hip Dysplasia Registry
Led by University of British Columbia · Updated on 2024-11-18
5000
Participants Needed
1
Research Sites
643 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children. DDH represents a spectrum of issues affecting the hip joint - a "ball-and-socket" joint. When the femoral head (the "ball) is seated properly in the acetabulum (the "socket"), the hip is stable and can develop normally. However, when the femoral head is not well-seated, the hip can become unstable or dislocate. This instability or dislocation of the femoral head prevents the hip joint from developing normally during infancy and early childhood. If left undetected or untreated, it can lead to debilitating complications later in life. Development of a comprehensive, prospective international registry for all infants and children with DDH will provide the potential to impact all infants born, not only in British Columbia, but around the world. The purpose of this initiative is to identify best practices and standardize treatment and management strategies in order to optimize clinical and functional outcomes for patients with DDH. This registry includes targeted specific outcomes that will be investigated, in addition to the general collection of data on all patients diagnosed with any form of DDH up to the age of 10 years.
CONDITIONS
Official Title
Global Hip Dysplasia Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between the ages of 0 and 10 years at time of initial diagnosis
- Referred for DDH screening due to specific risk factors or diagnosed with DDH
- Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging
You will not qualify if you...
- Known or suspected neuromuscular, collagen, chromosomal, or lower extremity congenital anomalies
- Teratologic hip dislocation (syndromic-associated dislocations)
- Over 10 years of age at initial diagnosis
- Received prior treatment for DDH without appropriate imaging or documentation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
British Columbia Children's Hospital
Vancouver, British Columbia, Canada, V6H 3N1
Actively Recruiting
Research Team
E
Emily K Schaeffer, PhD
CONTACT
A
Ashley L Munoz, BSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here